New drug duo shows promise for rare blood cancer in early trial
NCT ID NCT04646395
First seen Apr 28, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study tests a combination of two drugs, acalabrutinib and tafasitamab, in about 26 people with marginal zone lymphoma that has come back after prior treatment. The goal is to see how well the drugs shrink tumors and to check for side effects. Participants receive treatment for up to 24 cycles and are followed for about 3 years after the last dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Spedali Civili di Brescia
Brescia, Italy
-
AUSL Ravenna U.O. Ematologia
Ravenna, 48121, Italy
-
Azienda Ospedaliera - IRCCS - Arcispedale Santa Maria Nuova
Reggio Emilia, Italy
-
Fondazione IRCCS - Istituto Nazionale dei Tumori
Milan, Italy
-
Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico
Milan, Italy
-
Oncology Institute of Southern Switzerland
Bellinzona, 6500, Switzerland
-
Ospedale Maggiore della Carità
Novara, Italy
-
Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi
Varese, Italy
-
University of Wien
Vienna, 1190, Austria
Conditions
Explore the condition pages connected to this study.